During the past decade, Cukurova University Medical Faculty Balcali Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cukurova University Medical Faculty Balcali Hospital" #1 sponsor was "Celgene" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Cukurova University" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cukurova University Medical Faculty Balcali Hospital" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials as a collaborator, "Pierrel Research Europe GmbH" with 1 trials as a collaborator and "University Hospital Tuebingen" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cukurova University Medical Faculty Balcali Hospital" are "Amyloidosis" (1 trials), "Anaemia" (1 trials), "Asphyxia Neonatorum" (1 trials), "Atrial Fibrillation" (1 trials) and "Behçet's Syndrome" (1 trials). Many other conditions were trialed in "Cukurova University Medical Faculty Balcali Hospital" in a lesser frequency.

Most popular intervention types in "Cukurova University Medical Faculty Balcali Hospital" are "Drug" (20 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (2 trials), "Luspatercept" (2 trials), "Mitapivat" (2 trials) and "Placebo Matching Mitapivat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cukurova University Medical Faculty Balcali Hospital" are 19 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Cukurova University Medical Faculty Balcali Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Cukurova University Medical Faculty Balcali Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cukurova University Medical Faculty Balcali Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".